Home › Asset managers › Compare 2025-2026 › American Century vs ProShares
American Century 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,123 | 24,929 | 1,050 | 144 | 96.0% | 95.7% |
| Board proposals | 23,824 | 22,789 | 917 | 118 | 96.1% | 95.9% |
| E&S shareholder proposals | 175 | 156 | 19 | 0 | 89.1% | 89.1% |
| Other items | 2,124 | 1,984 | 114 | 26 | 94.6% | 94.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,035 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | ProShares |
|---|---|---|---|---|---|---|
| IBEX Limited | December 5, 2025 | To approve the Amended and Restated Ibex Limited Long-Term Inceritive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| IBOTTA INC. | May 19, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| IDEAYA BIOSCIENCES, INC. | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| IES HOLDINGS, INC. | February 19, 2026 | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 9 funds |
| IMMUNOME INC. | June 9, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 11 funds |
| IMPINJ, INC. | May 28, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| INFINITY NATURAL RESOURCES, INC. | June 9, 2026 | To approve, by a non-binding advisory vote, our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| INNODATA INC. | June 4, 2026 | Approval of the Amended and Restated Innodata Inc. Equity Compensation Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| INNOVIVA, INC. | May 4, 2026 | Approval of the 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 17 funds |
| INOGEN, INC. | June 5, 2026 | To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| INSPIRE MEDICAL SYSTEMS, INC. | April 30, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| INTEGRA LIFESCIENCES HOLDINGS CORP. | May 7, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| INTEL CORPORATION | May 13, 2026 | Advisory vote on executive compensation (Say-On-Pay). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 31 funds |
| INTELLIA THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 12 funds |
| INTERNATIONAL BUSINESS MACHINES CORP. | April 28, 2026 | Approval of 2026 Long-Term Performance Plan Compensation |
Board | For | FOR 15 funds |
AGAINST 27 funds |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | April 29, 2026 | Approve, on an advisory basis, the compensation of our named executive officers in 2025. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 19 funds |
| INTERNATIONAL MONEY EXPRESS, INC. | December 9, 2025 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intermex's named executive officers that is based on or otherwise relates to the Merger Agreement and/or the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| INVITATION HOMES INC. | May 7, 2026 | To approve the Invitation Homes Inc. 2026 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 18 funds |
| INVITATION HOMES INC. | May 7, 2026 | To approve, in a non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 18 funds |
| IRONWOOD PHARMACEUTICALS, INC. | June 16, 2026 | Approval of an amendment to Ironwood Pharmaceuticals, Inc. Amended and Restated 2019 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 10,000,000 shares. Compensation |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| IRadimed Corporation | June 23, 2026 | Election of Directors: James Hawkins Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 9 funds |
| IRadimed Corporation | June 23, 2026 | Election of Directors: Roger Susi Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 9 funds |
| ITT INC. | May 21, 2026 | Approval of a non-binding advisory vote on executive compensation Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| IVANHOE ELECTRIC INC. | June 4, 2026 | To seek a non-binding, advisory vote on the approval of our executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| ImmunityBio, Inc. | June 9, 2026 | Election of Directors: Patrick Soon-Shiong, M.D. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 12 funds |
| Integer Holdings Corporation | May 20, 2026 | To approve the Integer Holdings Corporation 2026 0mnibus Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| J & J SNACK FOODS CORP. | February 12, 2026 | ADVISORY VOTE ON APPROVAL OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 15 funds |
| JACK HENRY & ASSOCIATES, INC. | November 12, 2025 | To approve the Company's 2025 Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 21 funds |
| JACK HENRY & ASSOCIATES, INC. | November 12, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 21 funds |
| JACK IN THE BOX INC. | February 27, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | Contested | AGAINST 1 fund |
FOR 9 funds |
| JANUS HENDERSON GROUP PLC | May 29, 2026 | Advisory Say-on-Pay Vote on Executive Compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| JANUX THERAPEUTICS, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| JAZZ PHARMACEUTICALS PLC | July 24, 2025 | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 10 funds |
| JBG SMITH PROPERTIES | April 30, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement ("Say-on-Pay"). Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 14 funds |
| JELD-WEN HOLDING, INC. | April 22, 2026 | To approve the 2026 Omnibus Equity Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| JFROG LTD. | May 20, 2026 | To approve on a nonbinding, advisory basis the compensation paid to us to our named executive officers, as disclosed in this proxy statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| JOBY AVIATION INCORPORATION | June 2, 2026 | Approval, in a non-binding advisory vote, of the compensation of Joby's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| JOHN B. SANFILIPPO & SON, INC. | October 29, 2025 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| JOHNSON OUTDOORS INC. | February 26, 2026 | To adopt and approve an amendment to the Johnson Outdoors Inc. 2020 Long-Term Stock Incentive Plan to increase the number of shares available to be issued under the plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| JOHNSON OUTDOORS INC. | February 26, 2026 | To approve a non-binding advisory proposal on executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| James River Group Holdings, Ltd. | October 23, 2025 | To approve the amendment of the James River Group Holdings, Ltd. 2014 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| KAISER ALUMINUM CORPORATION | June 4, 2026 | APPROVAL OF AMENDMENT AND RESTATEMENT OF KAISER ALUMINUM CORPORATION 2021 EQUITY AND INCENTIVE COMPENSATION PLAN Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| KEARNY FINANCIAL CORP | October 21, 2025 | Approval of an advisory, non-binding resolution to approve our executive compensation as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| KENNEDY-WILSON HOLDINGS, INC. | June 10, 2026 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Kennedy Wilson to its named executive officers in connection with the transactions contemplated by the Merger Agreement (the ''Advisory Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 13 funds |
| KEROS THERAPEUTICS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| KEYCORP | May 14, 2026 | Approval of the 2026 Equity Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 20 funds |
| KFORCE INC. | April 22, 2026 | Advisory vote on Kforce's executive compensation. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 9 funds |
| KFORCE INC. | April 22, 2026 | Approve the Kforce Inc. 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| KILROY REALTY CORPORATION | May 19, 2026 | Approval of the amendment and restatement of the Company's 2006 Incentive Award Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| KINDERCARE LEARNING COMPANIES, INC. | June 4, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| KINGSWAY FINANCIAL SERVICES INC. | May 18, 2026 | To approve an amendment to the Corporation's 2020 Equity Incentive Plan dated September 21, 2020 to increase the number of Common Shares reserved for issuance; and Compensation |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| KINIKSA PHARMACEUTICAL INTERNATIONAL PLC | May 29, 2026 | To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| KINIKSA PHARMACEUTICAL INTERNATIONAL PLC | May 29, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| KIRBY CORPORATION | April 27, 2026 | Approval of Amendment of the 2005 Stock and Incentive Plan Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| KLAVIYO, INC. | June 9, 2026 | To approve, on a non-binding advisory basis, the compensation of Klaviyo's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| KODIAK GAS SERVICES, INC. | May 7, 2026 | Advisory, non-binding vote to approve the compensation of Kodiak Gas Services, Inc.'s named executive officers for 2025; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 13 funds |
| KODIAK SCIENCES INC. | June 2, 2026 | Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| KORRO BIO, INC. | June 10, 2026 | Non-binding advisory vote to approve the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| KRATOS DEFENSE & SEC SOLUTIONS, INC. | May 12, 2026 | To approve an amendment and restatement of our 2023 Equity Incentive Plan to increase the number of shares of common stock issuable under such plan by 6,900,000 shares. Compensation |
Board | For | AGAINST 5 funds |
FOR 17 funds |
| KRONOS WORLDWIDE, INC. | May 13, 2026 | Election of Directors: Brian W. Christian Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 9 funds |
| KRONOS WORLDWIDE, INC. | May 13, 2026 | Election of Directors: Loretta J. Feehan Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 9 funds |
| KRONOS WORLDWIDE, INC. | May 13, 2026 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 9 funds |
| KRYSTAL BIOTECH, INC. | May 15, 2026 | Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 15 funds |
| KULICKE AND SOFFA INDUSTRIES, INC. | March 4, 2026 | To approve, on a non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 12 funds |
| KURA ONCOLOGY, INC. | June 4, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| KYMERA THERAPEUTICS, INC. | June 24, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers; and Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| LA-Z-BOY INCORPORATED | August 26, 2025 | To approve, through a non-binding advisory vote, the compensation of the company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 12 funds |
| LAKELAND FINANCIAL CORPORATION | April 14, 2026 | APPROVAL, by non-binding vote, of the Company's compensation of certain executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 17 funds |
| LAKELAND INDUSTRIES, INC. | June 16, 2026 | Approve the Lakeland Industries, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| LAM RESEARCH CORPORATION | November 4, 2025 | Advisory vote to approve the compensation of the named executive officers of Lam Research, or "Say on Pay." Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 32 funds |
| LAM RESEARCH CORPORATION | November 4, 2025 | Approval of the adoption of the Lam 2025 Stock Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 32 funds |
| LAMAR ADVERTISING COMPANY | May 14, 2026 | Approval of an amendment and restatement of the Company's 1996 Equity Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 9 funds |
| LARIMAR THERAPEUTICS, INC. | May 19, 2026 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| LAUREATE EDUCATION, INC. | May 21, 2026 | To approve the Laureate Education, Inc. 2026 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| LCI INDUSTRIES | May 12, 2026 | To approve the LCI Industries Amended 2018 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| LEGENCE CORP | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| LENDINGCLUB CORPORATION | June 2, 2026 | Approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 9 funds |
| LENDINGTREE INC | June 17, 2026 | Advisory vote to approve LendingTree, Inc.'s executive compensation (say-on-pay). Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| LIFE TIME GROUP HOLDINGS, INC. | April 22, 2026 | To approve, by a non-binding vote, the named executive officer compensation as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 9 funds |
| LIFE360, INC. | May 28, 2026 | An advisory, non-binding vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| LIFECORE BIOMEDICAL, INC | October 29, 2025 | To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| LIFECORE BIOMEDICAL, INC. | June 4, 2026 | To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| LIFECORE BIOMEDICAL, INC. | June 4, 2026 | To approve the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| LIFEVANTAGE CORPORATION | November 6, 2025 | To approve a non-binding, advisory resolution approving the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| LIFEVANTAGE CORPORATION | November 6, 2025 | To approve an amendment to the 2017 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| LIGAND PHARMACEUTICALS INCORPORATED | June 5, 2026 | Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan Compensation |
Board | For | AGAINST 4 funds |
FOR 15 funds |
| LIQUIDITY SERVICES, INC. | February 26, 2026 | Approval of an advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| LIVERAMP HOLDINGS, INC. | August 12, 2025 | Advisory (non-binding) vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 13 funds |
| LOANDEPOT, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of loanDepot's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| LOGITECH INTERNATIONAL S.A. | September 9, 2025 | Advisory vote on the Swiss Statutory Compensation Report for fiscal year 2025 Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| LOGITECH INTERNATIONAL S.A. | September 9, 2025 | Advisory vote to approve Named Executive Officers Compensation for fiscal year 2025 Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| LSI INDUSTRIES INC. | November 4, 2025 | Advisory vote on the compensation of the named executive officers as described in the Company's proxy statement (the "Say-on-Pay vote"). Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| LULULEMON ATHLETICA INC. | June 25, 2026 | Approval of an amendment to the 2023 Equity Incentive Plan to increase the share reserve. Compensation |
Board | Contested | AGAINST 12 funds |
FOR 18 funds |
| LUMENTUM HOLDINGS INC. | November 19, 2025 | To approve the 2025 Equity Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 9 funds |
| LUMENTUM HOLDINGS INC. | November 19, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| LYFT, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of our named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 4 funds |
| LegalZoom.com, Inc. | June 3, 2026 | To conduct an advisory vote on the compensation of the Company's named executive officers; and Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 14 funds |
| M-TRON INDUSTRIES, INC. | June 16, 2026 | To approve a non-binding advisory resolution regarding the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| MADISON SQUARE GARDEN ENTERTAINMENT CORP | December 10, 2025 | Approval of, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 9 funds |
| MAGNITE, INC. | June 8, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 9 funds |
← Previous Page 5 of 11 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.